Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 733 to 741 of 741 entries
Sorted by: Best Match Show Resources per page
Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Lambertini M, Blondeaux E, Bruzzone M, Perachino M, Anderson RA, de Azambuja E, Poorvu PD, Kim HJ, Villarreal-Garza C, Pistilli B, Vaz-Luis I, Saura C, Ruddy KJ, Franzoi MA, Sertoli C, Ceppi M, Azim HA, Amant F, Demeestere I, Del Mastro L, Partridge AH, Pagani O, Peccatori FA.
PMID: 34197218
J Clin Oncol. 2021 Oct 10;39(29):3293-3305. doi: 10.1200/JCO.21.00535. Epub 2021 Jul 01.

PURPOSE: Many patients and physicians remain concerned about the potential detrimental effects of pregnancy after breast cancer (BC) in terms of reproductive outcomes and maternal safety. This systematic review and meta-analysis aimed at providing updated evidence on these topics.METHODS:...

Cite
Lambertini M, Blondeaux E, Bruzzone M, et al. Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis. J Clin Oncol. 2021;39(29):3293-3305doi: 10.1200/JCO.21.00535.
Lambertini, M., Blondeaux, E., Bruzzone, M., Perachino, M., Anderson, R. A., de Azambuja, E., Poorvu, P. D., Kim, H. J., Villarreal-Garza, C., Pistilli, B., Vaz-Luis, I., Saura, C., Ruddy, K. J., Franzoi, M. A., Sertoli, C., Ceppi, M., Azim, H. A., Amant, F., Demeestere, I., Del Mastro, L., Partridge, A. H., Pagani, O., & Peccatori, F. A. (2021). Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(29), 3293-3305. https://doi.org/10.1200/JCO.21.00535
Lambertini, Matteo, et al. "Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 39,29 (2021): 3293-3305. doi: https://doi.org/10.1200/JCO.21.00535
Lambertini M, Blondeaux E, Bruzzone M, Perachino M, Anderson RA, de Azambuja E, Poorvu PD, Kim HJ, Villarreal-Garza C, Pistilli B, Vaz-Luis I, Saura C, Ruddy KJ, Franzoi MA, Sertoli C, Ceppi M, Azim HA, Amant F, Demeestere I, Del Mastro L, Partridge AH, Pagani O, Peccatori FA. Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis. J Clin Oncol. 2021 Oct 10;39(29):3293-3305. doi: 10.1200/JCO.21.00535. Epub 2021 Jul 01. PMID: 34197218.
Copy Download .nbib Format: NLM
Social Engineering Attacks During the COVID-19 Pandemic.

SN computer science

Venkatesha S, Reddy KR, Chandavarkar BR.
PMID: 33585823
SN Comput Sci. 2021;2(2):78. doi: 10.1007/s42979-020-00443-1. Epub 2021 Feb 06.

The prevailing conditions surrounding the COVID-19 pandemic has shifted a variety of everyday activities onto platforms on the Internet. This has led to an increase in the number of people present on these platforms and also led to jump...

Cite
Venkatesha S, Reddy KR, Chandavarkar BR. Social Engineering Attacks During the COVID-19 Pandemic. SN Comput Sci. 2021;2(2):78doi: 10.1007/s42979-020-00443-1.
Venkatesha, S., Reddy, K. R., & Chandavarkar, B. R. (2021). Social Engineering Attacks During the COVID-19 Pandemic. SN computer science, 2(2), 78. https://doi.org/10.1007/s42979-020-00443-1
Venkatesha, Sushruth, et al. "Social Engineering Attacks During the COVID-19 Pandemic." SN computer science vol. 2,2 (2021): 78. doi: https://doi.org/10.1007/s42979-020-00443-1
Venkatesha S, Reddy KR, Chandavarkar BR. Social Engineering Attacks During the COVID-19 Pandemic. SN Comput Sci. 2021;2(2):78. doi: 10.1007/s42979-020-00443-1. Epub 2021 Feb 06. PMID: 33585823; PMCID: PMC7866964.
Copy Download .nbib Format: NLM
A Prospective Assessment of Opioid Utilization Post-Operatively in Orthopaedic Sports Medicine Surgeries.

The archives of bone and joint surgery

Capelle JM, Reddy PJ, Nguyen AT, Israel HA, Kim C, Kaar SG.
PMID: 34692932
Arch Bone Jt Surg. 2021 Sep;9(5):503-511. doi: 10.22038/abjs.2020.49306.2455.

BACKGROUND: The healthcare system is plagued finding the balance between opioid use and abuse. Orthopaedic surgeons are expected to curtail the number of opioids prescribed in order to lower opioid abuse. We sought to prospectively evaluate opioid consumption following...

Cite
Capelle JM, Reddy PJ, Nguyen AT, et al. A Prospective Assessment of Opioid Utilization Post-Operatively in Orthopaedic Sports Medicine Surgeries. Arch Bone Jt Surg. 2021;9(5):503-511doi: 10.22038/abjs.2020.49306.2455.
Capelle, J. M., Reddy, P. J., Nguyen, A. T., Israel, H. A., Kim, C., & Kaar, S. G. (2021). A Prospective Assessment of Opioid Utilization Post-Operatively in Orthopaedic Sports Medicine Surgeries. The archives of bone and joint surgery, 9(5), 503-511. https://doi.org/10.22038/abjs.2020.49306.2455
Capelle, John M, et al. "A Prospective Assessment of Opioid Utilization Post-Operatively in Orthopaedic Sports Medicine Surgeries." The archives of bone and joint surgery vol. 9,5 (2021): 503-511. doi: https://doi.org/10.22038/abjs.2020.49306.2455
Capelle JM, Reddy PJ, Nguyen AT, Israel HA, Kim C, Kaar SG. A Prospective Assessment of Opioid Utilization Post-Operatively in Orthopaedic Sports Medicine Surgeries. Arch Bone Jt Surg. 2021 Sep;9(5):503-511. doi: 10.22038/abjs.2020.49306.2455. PMID: 34692932; PMCID: PMC8503755.
Copy Download .nbib Format: NLM
India led health innovation(s) for achieving the SDG health goal in the global South.

Perspectives in public health

Reddy KS.
PMID: 35018855
Perspect Public Health. 2022 Jan;142(1):20-21. doi: 10.1177/17579139211013404.

No abstract available.

Cite
Reddy KS. India led health innovation(s) for achieving the SDG health goal in the global South. Perspect Public Health. 2022;142(1):20-21doi: 10.1177/17579139211013404.
Reddy, K. S. (2022). India led health innovation(s) for achieving the SDG health goal in the global South. Perspectives in public health, 142(1), 20-21. https://doi.org/10.1177/17579139211013404
Reddy, K S. "India led health innovation(s) for achieving the SDG health goal in the global South." Perspectives in public health vol. 142,1 (2022): 20-21. doi: https://doi.org/10.1177/17579139211013404
Reddy KS. India led health innovation(s) for achieving the SDG health goal in the global South. Perspect Public Health. 2022 Jan;142(1):20-21. doi: 10.1177/17579139211013404. PMID: 35018855.
Copy Download .nbib Format: NLM
Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Moy B, Rumble RB, Come SE, Davidson NE, Di Leo A, Gralow JR, Hortobagyi GN, Yee D, Smith IE, Chavez-MacGregor M, Nanda R, McArthur HL, Spring L, Reeder-Hayes KE, Ruddy KJ, Unger PS, Vinayak S, Irvin WJ, Armaghani A, Danso MA, Dickson N, Turner SS, Perkins CL, Carey LA.
PMID: 34324366
J Clin Oncol. 2021 Dec 10;39(35):3938-3958. doi: 10.1200/JCO.21.01374. Epub 2021 Jul 29.

PURPOSE: This guideline updates recommendations of the ASCO guideline on chemotherapy and targeted therapy for patients with human epidermal growth factor receptor 2-negative metastatic breast cancer (MBC) that is either endocrine-pretreated or hormone receptor (HR)-negative.METHODS: An Expert Panel conducted...

Cite
Moy B, Rumble RB, Come SE, et al. Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update. J Clin Oncol. 2021;39(35):3938-3958doi: 10.1200/JCO.21.01374.
Moy, B., Rumble, R. B., Come, S. E., Davidson, N. E., Di Leo, A., Gralow, J. R., Hortobagyi, G. N., Yee, D., Smith, I. E., Chavez-MacGregor, M., Nanda, R., McArthur, H. L., Spring, L., Reeder-Hayes, K. E., Ruddy, K. J., Unger, P. S., Vinayak, S., Irvin, W. J., Armaghani, A., Danso, M. A., Dickson, N., Turner, S. S., Perkins, C. L., & Carey, L. A. (2021). Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(35), 3938-3958. https://doi.org/10.1200/JCO.21.01374
Moy, Beverly, et al. "Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 39,35 (2021): 3938-3958. doi: https://doi.org/10.1200/JCO.21.01374
Moy B, Rumble RB, Come SE, Davidson NE, Di Leo A, Gralow JR, Hortobagyi GN, Yee D, Smith IE, Chavez-MacGregor M, Nanda R, McArthur HL, Spring L, Reeder-Hayes KE, Ruddy KJ, Unger PS, Vinayak S, Irvin WJ, Armaghani A, Danso MA, Dickson N, Turner SS, Perkins CL, Carey LA. Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update. J Clin Oncol. 2021 Dec 10;39(35):3938-3958. doi: 10.1200/JCO.21.01374. Epub 2021 Jul 29. PMID: 34324366.
Copy Download .nbib Format: NLM
The shifting shape of genomes: dynamics of heterochromatin interactions at the nuclear lamina.

Current opinion in genetics & development

Hoskins VE, Smith K, Reddy KL.
PMID: 33774266
Curr Opin Genet Dev. 2021 Apr;67:163-173. doi: 10.1016/j.gde.2021.02.003. Epub 2021 Mar 25.

The nucleus is a highly structured organelle with many chromatin and protein compartments that partition the genome into regulatory domains. One such a compartment within the mammalian nucleus is the microenvironment underlying the nuclear envelope (NE) where intermediate filament...

Cite
Hoskins VE, Smith K, Reddy KL. The shifting shape of genomes: dynamics of heterochromatin interactions at the nuclear lamina. Curr Opin Genet Dev. 2021;67:163-173doi: 10.1016/j.gde.2021.02.003.
Hoskins, V. E., Smith, K., & Reddy, K. L. (2021). The shifting shape of genomes: dynamics of heterochromatin interactions at the nuclear lamina. Current opinion in genetics & development, 67163-173. https://doi.org/10.1016/j.gde.2021.02.003
Hoskins, Victoria E, et al. "The shifting shape of genomes: dynamics of heterochromatin interactions at the nuclear lamina." Current opinion in genetics & development vol. 67 (2021): 163-173. doi: https://doi.org/10.1016/j.gde.2021.02.003
Hoskins VE, Smith K, Reddy KL. The shifting shape of genomes: dynamics of heterochromatin interactions at the nuclear lamina. Curr Opin Genet Dev. 2021 Apr;67:163-173. doi: 10.1016/j.gde.2021.02.003. Epub 2021 Mar 25. PMID: 33774266; PMCID: PMC8489734.
Copy Download .nbib Format: NLM
The transcription factor ZIP-1 promotes resistance to intracellular infection in Caenorhabditis elegans.

Nature communications

Lažetić V, Wu F, Cohen LB, Reddy KC, Chang YT, Gang SS, Bhabha G, Troemel ER.
PMID: 35013162
Nat Commun. 2022 Jan 10;13(1):17. doi: 10.1038/s41467-021-27621-w.

Defense against intracellular infection has been extensively studied in vertebrate hosts, but less is known about invertebrate hosts; specifically, the transcription factors that induce defense against intracellular intestinal infection in the model nematode Caenorhabditis elegans remain understudied. Two different...

Cite
Lažetić V, Wu F, Cohen LB, et al. The transcription factor ZIP-1 promotes resistance to intracellular infection in Caenorhabditis elegans. Nat Commun. 2022;13(1):17doi: 10.1038/s41467-021-27621-w.
Lažetić, V., Wu, F., Cohen, L. B., Reddy, K. C., Chang, Y. T., Gang, S. S., Bhabha, G., & Troemel, E. R. (2022). The transcription factor ZIP-1 promotes resistance to intracellular infection in Caenorhabditis elegans. Nature communications, 13(1), 17. https://doi.org/10.1038/s41467-021-27621-w
Lažetić, Vladimir, et al. "The transcription factor ZIP-1 promotes resistance to intracellular infection in Caenorhabditis elegans." Nature communications vol. 13,1 (2022): 17. doi: https://doi.org/10.1038/s41467-021-27621-w
Lažetić V, Wu F, Cohen LB, Reddy KC, Chang YT, Gang SS, Bhabha G, Troemel ER. The transcription factor ZIP-1 promotes resistance to intracellular infection in Caenorhabditis elegans. Nat Commun. 2022 Jan 10;13(1):17. doi: 10.1038/s41467-021-27621-w. PMID: 35013162.
Copy Download .nbib Format: NLM
Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Chalasani NP, Porter K, Bhattacharya A, Book AJ, Neis BM, Xiong KM, Ramasubramanian TS, Edwards DK, Chen I, Johnson S, Roberts LR, Kisiel JB, Reddy KR, Singal AG, Olson MC, Bruinsma JJ.
PMID: 34391922
Clin Gastroenterol Hepatol. 2022 Jan;20(1):173-182.e7. doi: 10.1016/j.cgh.2021.08.010. Epub 2021 Aug 13.

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. Although biannual ultrasound surveillance with or without α-fetoprotein (AFP) testing is recommended for at-risk patients, sensitivity for early stage HCC, for which potentially curative treatments...

Cite
Chalasani NP, Porter K, Bhattacharya A, et al. Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2021;20(1):173-182.e7doi: 10.1016/j.cgh.2021.08.010.
Chalasani, N. P., Porter, K., Bhattacharya, A., Book, A. J., Neis, B. M., Xiong, K. M., Ramasubramanian, T. S., Edwards, D. K., Chen, I., Johnson, S., Roberts, L. R., Kisiel, J. B., Reddy, K. R., Singal, A. G., Olson, M. C., & Bruinsma, J. J. (2022). Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 20(1), 173-182.e7. https://doi.org/10.1016/j.cgh.2021.08.010
Chalasani, Naga P, et al. "Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. 20,1 (2022): 173-182.e7. doi: https://doi.org/10.1016/j.cgh.2021.08.010
Chalasani NP, Porter K, Bhattacharya A, Book AJ, Neis BM, Xiong KM, Ramasubramanian TS, Edwards DK, Chen I, Johnson S, Roberts LR, Kisiel JB, Reddy KR, Singal AG, Olson MC, Bruinsma JJ. Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2022 Jan;20(1):173-182.e7. doi: 10.1016/j.cgh.2021.08.010. Epub 2021 Aug 13. PMID: 34391922.
Copy Download .nbib Format: NLM
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic.

medRxiv : the preprint server for health sciences

Baggett TP, Scott JA, Le MH, Shebl FM, Panella C, Losina E, Flanagan C, Gaeta JM, Neilan A, Hyle EP, Mohareb A, Reddy KP, Siedner MJ, Harling G, Weinstein MC, Ciaranello A, Kazemian P, Freedberg KA.
PMID: 32817967
medRxiv. 2020 Oct 20; doi: 10.1101/2020.08.07.20170498.

IMPORTANCE: Approximately 356,000 people stay in homeless shelters nightly in the US. They are at high risk for COVID-19.OBJECTIVE: To assess clinical outcomes, costs, and cost-effectiveness of strategies for COVID-19 management among sheltered homeless adults.DESIGN: We developed a dynamic...

Cite
Baggett TP, Scott JA, Le MH, et al. Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic. medRxiv. 2020;doi: 10.1101/2020.08.07.20170498.
Baggett, T. P., Scott, J. A., Le, M. H., Shebl, F. M., Panella, C., Losina, E., Flanagan, C., Gaeta, J. M., Neilan, A., Hyle, E. P., Mohareb, A., Reddy, K. P., Siedner, M. J., Harling, G., Weinstein, M. C., Ciaranello, A., Kazemian, P., & Freedberg, K. A. (2020). Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.08.07.20170498
Baggett, Travis P, et al. "Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic." medRxiv : the preprint server for health sciences vol. (2020). doi: https://doi.org/10.1101/2020.08.07.20170498
Baggett TP, Scott JA, Le MH, Shebl FM, Panella C, Losina E, Flanagan C, Gaeta JM, Neilan A, Hyle EP, Mohareb A, Reddy KP, Siedner MJ, Harling G, Weinstein MC, Ciaranello A, Kazemian P, Freedberg KA. Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic. medRxiv. 2020 Oct 20; doi: 10.1101/2020.08.07.20170498. PMID: 32817967; PMCID: PMC7430611.
Copy Download .nbib Format: NLM
Showing 733 to 741 of 741 entries